Insulin Fiasp

DRUG2 trials

Sponsors

Institut de Recherches Cliniques de Montreal, Boston Medical Center

Conditions

Type 1 Diabetes MellitusType 2 Diabetes Treated With Insulin

Phase 3

Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus

CompletedNCT04460326

Boston Medical CenterType 2 Diabetes Treated With Insulin

Start: 2020-12-07End: 2023-05-27Updated: 2024-03-19

Phase 4

Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes

CompletedNCT03659799

Institut de Recherches Cliniques de MontrealType 1 Diabetes Mellitus

Start: 2019-04-12End: 2023-03-30Updated: 2023-09-01

Related Papers

Assessing the influence of insulin type (ultra-rapid vs rapid insulin) and exercise timing on postprandial exercise-induced hypoglycaemia risk in individuals with type 1 diabetes: a randomised controlled trial.

2024-07-294 citations